医学
心脏病学
内科学
四分位间距
蒂米
心肌梗塞
急性冠脉综合征
罪魁祸首
肌钙蛋白
心导管术
人口
肌钙蛋白T
经皮冠状动脉介入治疗
环境卫生
作者
H. Pendell Meyers,Alexander Bracey,Daniel Lee,Andrew Lichtenheld,Wei J. Li,Daniel Singer,Jesse Kane,Kenneth W. Dodd,Kristen Meyers,Henry C. Thode,Gautam R. Shroff,Adam J. Singer,Stephen W. Smith
标识
DOI:10.1016/j.jemermed.2020.10.026
摘要
Abstract Background The current ST-elevation myocardial infarction (STEMI) vs. non-STEMI (NSTEMI) paradigm prevents some NSTEMI patients with acute coronary occlusion from receiving emergent reperfusion, in spite of their known increased mortality compared with NSTEMI without occlusion. We have proposed a new paradigm known as occlusion MI vs. nonocclusion MI (OMI vs. NOMI). Objective We aimed to compare the two paradigms within a single population. We hypothesized that STEMI(–) OMI would have characteristics similar to STEMI(+) OMI but longer time to catheterization. Methods We performed a retrospective review of a prospectively collected acute coronary syndrome population. OMI was defined as an acute culprit and either TIMI 0–2 flow or TIMI 3 flow plus peak troponin T > 1.0 ng/mL. We collected electrocardiograms, demographic characteristics, laboratory results, angiographic data, and outcomes. Results Among 467 patients, there were 108 OMIs, with only 60% (67 of 108) meeting STEMI criteria. Median peak troponin T for the STEMI(+) OMI, STEMI(–) OMI, and no occlusion groups were 3.78 (interquartile range [IQR] 2.18–7.63), 1.87 (IQR 1.12–5.48), and 0.00 (IQR 0.00–0.08). Median time from arrival to catheterization was 41 min (IQR 23–86 min) for STEMI(+) OMI compared with 437 min (IQR 85–1590 min) for STEMI(–) OMI (p Conclusions STEMI(–) OMI patients had significant delays to catheterization but adverse outcomes more similar to STEMI(+) OMI than those with no occlusion. These data support the OMI/NOMI paradigm and the importance of further research into emergent reperfusion for STEMI(–) OMI.
科研通智能强力驱动
Strongly Powered by AbleSci AI